María Cruz, Ph.D.
Biography
Dr. María Cruz, is a clinical embryologist at IVI Madrid and a faculty for the Master’s Degree in Biology and Technology Applied to Assisted Human Reproduction at the European University of Madrid. She obtained her B.S.c in in Biological Sciences at the Complutense University of Madrid and received her Ph.D. from University of Valencia. Dra. Cruz also obtained a Master’s Degree in Biotechnology of Assisted Human Reproduction and a course of Research Methodology applied to Design and Statistics in Health sciences from the Autonoma University of Barcelona. Her research interests include Endocrinology, time-lapse analysis and genetic polymorphisms.
Publications
-
Infertility and reproductive rights after the COVID-19 pandemic.
Trinchant RM Cruz M Marqueta J Requena A
Reprod Biomed Online. 2020 May 19:S1472-6483(20)30275-3. doi: 10.1016/j.rbmo.2020.05.007. Online ahead of print. -
A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy.
Requena A Cruz M Vergara V Prados N Galliano D Pellicer A
Reprod Biomed Online. 2020 Jul;41(1):1-5. doi: 10.1016/j.rbmo.2020.04.015. Epub 2020 Apr 25. -
Use of granulocyte colony-stimulating factor in ART treatment does not increase the risk of adverse perinatal outcomes.
Cruz M Alecsandru D García-Velasco JA Requena A
Reprod Biomed Online. 2019 Sep 19. pii: S1472-6483(19)30744-8. doi: 10.1016/j.rbmo.2019.09.008. [Epub ahead of print] -
Donor IUI is equally effective for heterosexual couples, single women and lesbians, but autologous IUI does worse.
Soares SR Cruz M Vergara V Requena A García-Velasco JA
Hum Reprod. 2019 Nov 6. pii: dez179. doi: 10.1093/humrep/dez179. [Epub ahead of print] -
Impact of hypogonadotropic hypogonadism on ovarian reserve and response.
Cecchino GN Canillas GM Cruz M García-Velasco JA
J Assist Reprod Genet. 2019 Nov;36(11):2379-2384. doi: 10.1007/s10815-019-01587-7. Epub 2019 Oct 18 -
Is the transport of frozen embryos a good option to improve results in a transnational oocyte donation program?
Requena A Cruz M Pellicer A
Hum Reprod. 2019 Jul 8;34(7):1383-1385. doi: 10.1093/humrep/dez093. No abstract available. -
Serum and follicular fluid Stem Cell Factor assay in IVF poor responder and normal responder patients: a predictive biomarker of oocyte retrieval.
Cozzolino M Cruz M Patel A Patel J Pacheco A Garcia-Velasco JA
Arch Gynecol Obstet. 2019 May 6. doi: 10.1007/s00404-019-05172-2. [Epub ahead of print] -
Frozen embryo transfer after PGT-A cycles: To wait or not to wait?
Cerillo M Cruz m Basile N Guillen A Bronet F García-Velasco A
Medicina Reproductiva y Embriología ClínicaIn press, corrected proofAvailable online 5 November 2020 -
Magnetic-Activated Cell Sorting (MACS): A Useful Sperm-Selection Technique in Cases of High Levels of Sperm DNA Fragmentation.
Pacheco A Blanco A Bronet F Cruz M García-Fernández J García Velasco JA
J Clin Med. 2020 Dec 8;9(12):E3976. doi: 10.3390/jcm9123976. -
Small-sized follicles could contribute to high-order multiple pregnancies: outcomes of 6552 intrauterine insemination cycles.
Giles J Cruz M González-Ravina C Caligara C Martínez JC Vergara V Requena A
Reprod Biomed Online, 37(5):549-554, 2018.
Read more
Presentations
- Giles J Cruz M Alamá P Laura Caracena Vidal C Bosch E P-863 PROGNOSTIC FACTORS OF OVARIAN RESPONSE AFTER FOLLICULAR PROTOCOL WITH MPA TRIGGER WITH GnRH AGONIST.. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- Agudo D Castro E Pacheco A Irene Martín Patón Cruz M Bronet F O-107 DOES TOBACCO AFFECT FOLLICULAR AND EMBRYO HEALTH?. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- Prados N González-Ravina C Vergara V Javier Herrero Cruz M Requena A P-980 RISK FACTOR ANALYSIS FOR SARS-COV-2 SEROPOSITIVITY WITHIN ASSISTED REPRODUCTIVE. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- Cruz M Ruiz ME P-1011 HP-HMG IN MONOTHERAPY IMPROVES CLINICAL OUTCOMES IN YOUNG WOMEN. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- Ortega I Alvarez de la Fuente A Sonia Matey Elizabet Henzenn Cruz M Pacheco A Antoni Duleba Garcia-Velasco JA P-854 RESVERATROL FOR PREVENTING OVARIAN HYPERSTIMULATION SYNDROME IN WOMEN AT RISK UNDERGOING EGG DONATION: A RANDOMIZED CONTROLLED STUDY. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- Cruz M Vergara V Requena A P-857 TYPE OF FOLLITROPIN ALFA FOR OVARIAN STIMULATION WITH MEDROXYPROGESTERONE ACETATE DOES NOT AFFECT CLINICAL OUTCOMES IN A DONOR-RECIPIENT PROGRAM. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- González-Ravina Vergara V Cruz M Prados N Requena A O-146 Is COVID-19 symptomatic triage enough? The limited value of serological testing. Presented at the 36th annual meeting of the European Society of Human Reproduction and Embryology, Copenhagen,Denmark, July 5-8, 2020
- Cecchino G Cerrillo M Cruz M Garcia Velasco J Retrospective analysis of DuoStim cycles shows similar overall performance and oocyte quality between follicular and luteal phase stimulation. Presented at the 33rd annual meeting of the European Society of Human Reproduction and Embryology, Geneva,Switerland, July 1-4,2018
- Cruz M Alecsandru D Garcia Velasco J Requena A Use of granulocyte colony-stimulating factor during an assisted reproductive treatment does not increase the risk of birth defects. Presented at the 33rd annual meeting of the European Society of Human Reproduction and Embryology, Geneva,Switerland, July 1-4,2018
- Cerrillo M Cruz M Ferrando R García Velasco JA Freeze-all strategy in endometriosis patients - a new indication?. , , July 2-5 ,2017
Read more